Patrick Kwan Selected Research

Anticonvulsants (Antiepileptic Drugs)

1/2021	Adverse events related to antiepileptic drugs.
1/2021	HLA Risk Alleles in Aromatic Antiepileptic Drug-Induced Maculopapular Exanthema.
10/2020	Antiepileptic drugs are not independently associated with cognitive dysfunction.
1/2020	Antiepileptic Drug Teratogenicity and De Novo Genetic Variation Load.
11/2019	Relative Seizure Relapse Risks Associated with Antiepileptic Drug Withdrawal After Different Seizure-Free Periods in Adults with Focal Epilepsy: A Prospective, Controlled Follow-Up Study.
1/2019	HLA-associated antiepileptic drug-induced cutaneous adverse reactions.
1/2019	Pharmacological outcomes in teenagers with newly diagnosed epilepsy: A 30-year cohort study.
1/2019	Epilepsy in Asia: Disease burden, management barriers, and challenges.
10/2018	Presentation and management of community-onset vs hospital-onset first seizures.
1/2018	Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrick Kwan Research Topics

Disease

86	Epilepsy (Aura) 01/2022 - 04/2002
49	Seizures (Absence Seizure) 03/2022 - 03/2002
23	Drug Resistant Epilepsy 01/2022 - 03/2002
10	Temporal Lobe Epilepsy 01/2022 - 02/2004
10	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2021 - 05/2007
7	Partial Epilepsies (Epilepsy, Partial) 01/2021 - 05/2010
6	Stroke (Strokes) 09/2022 - 06/2016
6	Hypersensitivity (Allergy) 05/2021 - 08/2009
5	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 03/2020
5	Ischemic Stroke 05/2021 - 01/2017
5	Exanthema (Rash) 01/2021 - 05/2007
3	Status Epilepticus (Complex Partial Status Epilepticus) 11/2022 - 12/2012
3	Sudden Unexpected Death in Epilepsy 01/2022 - 01/2020
3	Cognitive Dysfunction 12/2021 - 03/2002
3	Drug Hypersensitivity (Drug Allergy) 05/2021 - 07/2018
3	Idiopathic Generalized Epilepsy 12/2020 - 02/2016
3	Psychotic Disorders (Schizoaffective Disorder) 10/2020 - 10/2016
3	Mental Disorders (Mental Disorder) 01/2020 - 10/2011
3	Glioma (Gliomas) 01/2019 - 01/2016
3	Drug-Related Side Effects and Adverse Reactions 01/2019 - 01/2018
3	Febrile Seizures (Febrile Seizure) 03/2014 - 09/2010
2	Nervous System Diseases (Neurological Disorders) 03/2020 - 01/2020
2	Congenital Abnormalities (Deformity) 01/2020 - 12/2012
2	Craniocerebral Trauma (Head Injury) 12/2012 - 01/2005
2	Sleepiness 10/2011 - 05/2009
2	Dizziness (Lightheadedness) 10/2011 - 04/2011
1	Critical Illness (Critically Ill) 11/2022
1	Ketosis 11/2022
1	Psychogenic Nonepileptic Seizures 01/2022
1	Tuberous Sclerosis (Bourneville's Disease) 01/2022
1	Sleep Deprivation 01/2022
1	Sudden Death 12/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Infections 01/2021
1	COVID-19 01/2021
1	Gliosis 01/2021
1	Autoimmune Diseases of the Nervous System 01/2021

Drug/Important Bio-Agent (IBA)

49	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 03/2002
38	Pharmaceutical PreparationsIBA 01/2022 - 10/2002
14	Carbamazepine (Tegretol)FDA LinkGeneric 05/2021 - 05/2007
13	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2018
8	Glutamic Acid (Glutamate)FDA Link 10/2021 - 01/2016
8	HLA-B Antigens (HLA-B)IBA 05/2021 - 05/2007
7	Proteins (Proteins, Gene)FDA Link 11/2022 - 11/2013
7	perampanelIBA 10/2021 - 01/2013
5	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2020 - 10/2002
5	Phenytoin (Dilantin)FDA LinkGeneric 01/2018 - 05/2007
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 01/2018
4	Levetiracetam (Keppra)FDA LinkGeneric 01/2020 - 05/2010
4	Valproic Acid (Depakote)FDA LinkGeneric 01/2020 - 04/2009
4	Lamotrigine (Lamictal)FDA LinkGeneric 06/2017 - 05/2007
4	Phenobarbital (Luminal)FDA Link 03/2013 - 09/2004
3	Triglycerides (Triacylglycerol)IBA 11/2022 - 03/2019
3	Biological ProductsIBA 05/2020 - 03/2002
3	brivaracetamIBA 01/2016 - 01/2014
3	Sodium Channels (Sodium Channel)IBA 05/2014 - 11/2008
2	Glial Fibrillary Acidic ProteinIBA 09/2022 - 01/2019
2	CannabidiolIBA 01/2022 - 01/2020
2	Amyloid (Amyloid Fibrils)IBA 12/2021 - 01/2021
2	Immunoglobulin E (IgE)IBA 12/2020 - 02/2016
2	Glutathione (Reduced Glutathione)IBA 12/2020 - 01/2020
2	triheptanoinIBA 06/2020 - 03/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2016
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2020 - 05/2009
2	AcidsIBA 01/2018 - 01/2013
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018 - 01/2017
2	LigandsIBA 12/2015 - 01/2014
2	Voltage-Gated Sodium ChannelsIBA 05/2014 - 11/2008
2	Pregabalin (Lyrica)FDA Link 01/2014 - 10/2011
2	S-2-O-carbamoyl-1-o-chlorophenyl-ethanolIBA 04/2011 - 03/2010
2	Messenger RNA (mRNA)IBA 05/2009 - 11/2008
1	Phosphates (Orthophosphate)IBA 09/2022
1	Thioctic Acid (Lipoic Acid)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	trans-sodium crocetinate (crocetin)IBA 01/2022
1	PolyphenolsIBA 01/2022
1	3-methyl-N,N-diethyl-p-phenylenediamineIBA 01/2022
1	AntioxidantsIBA 01/2022
1	Illicit Drugs (Recreational Drugs)IBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2021
1	Glucose (Dextrose)FDA LinkGeneric 12/2021
1	AntibodiesIBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	CytokinesIBA 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	Aminobutyrates (Aminobutyric Acid)IBA 12/2020
1	Cytochrome P-450 CYP2C9IBA 08/2020
1	Glycogen Synthase Kinase 3IBA 05/2020
1	Glycogen Synthase (Synthase I)IBA 05/2020

Therapy/Procedure

30	Therapeutics 11/2022 - 04/2002
3	Electrodes (Electrode) 08/2019 - 03/2007
2	Wearable Electronic Devices 01/2022 - 01/2022
2	Treatment Delay 01/2021 - 01/2020
2	Transcranial Direct Current Stimulation 12/2016 - 09/2016
1	Patient Care 03/2022
1	Ketogenic Diet 10/2021
1	Lab-On-A-Chip Devices 05/2021
1	Injections 01/2021
1	Vagus Nerve Stimulation 01/2021
1	Immunomodulation 01/2021